Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells $116,051.10 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 5,566 shares of Privia Health Group stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $20.85, for a total transaction of $116,051.10. Following the completion of the transaction, the chief financial officer directly owned 214,847 shares in the company, valued at $4,479,559.95. This trade represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

David Mountcastle also recently made the following trade(s):

• On Monday, March 16th, David Mountcastle sold 6,391 shares of Privia Health Group stock. The shares were sold at an average price of $22.11, for a total transaction of $141,305.01.
• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The shares were sold at an average price of $21.52, for a total transaction of $141,278.80.
• On Thursday, March 12th, David Mountcastle sold 6,453 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total transaction of $141,320.70.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The stock was sold at an average price of $22.84, for a total transaction of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total transaction of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Stock Performance

NASDAQ PRVA opened at $22.71 on Thursday. The firm’s fifty day moving average price is $22.08 and its two-hundred day moving average price is $23.41. The stock has a market cap of $2.81 billion, a PE ratio of 133.59, a PEG ratio of 1.32 and a beta of 0.87. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. The firm had revenue of $541.17 million for the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The company’s revenue was up 17.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.21 earnings per share. As a group, sell-side analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

PRVA has been the topic of a number of research reports. Royal Bank Of Canada initiated coverage on shares of Privia Health Group in a research note on Friday, January 9th. They set an “outperform” rating and a $31.00 target price on the stock. Truist Financial boosted their target price on shares of Privia Health Group from $31.00 to $33.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research note on Friday, March 27th. Citigroup reduced their price objective on shares of Privia Health Group from $34.00 to $32.00 and set a “buy” rating on the stock in a research note on Tuesday, March 3rd. Finally, Wolfe Research set a $31.00 target price on Privia Health Group in a research report on Tuesday, January 6th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $31.13.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in Privia Health Group by 5.3% during the 3rd quarter. Vanguard Group Inc. now owns 12,098,933 shares of the company’s stock worth $301,263,000 after purchasing an additional 607,447 shares during the last quarter. Durable Capital Partners LP raised its position in Privia Health Group by 1.8% during the 3rd quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after purchasing an additional 203,842 shares during the last quarter. State Street Corp raised its position in Privia Health Group by 1.5% during the 2nd quarter. State Street Corp now owns 4,171,069 shares of the company’s stock worth $95,935,000 after purchasing an additional 61,853 shares during the last quarter. Van Berkom & Associates Inc. raised its position in Privia Health Group by 1.8% during the 4th quarter. Van Berkom & Associates Inc. now owns 3,844,256 shares of the company’s stock worth $91,147,000 after purchasing an additional 69,691 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Privia Health Group by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 2,814,290 shares of the company’s stock valued at $66,738,000 after acquiring an additional 31,204 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.